« Previous
Next »
American Heart Journal
Volume 149, Issue 6
, Pages 1003-1008
, June 2005
Development of a multicenter peripheral arterial interventional database: The PVD-QI2
References
- Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J. Clin. Epidemiol. 1990;43:597–606
- The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–515
- . Update on endovascular treatment of peripheral vascular disease: new tools, techniques, and indications. Tex. Heart. Inst. J. 2000;27:369–385
- Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery J. Vasc. Surg. 1986;4:80–94
- . Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. Radiology. 1991;181:277–281
- Reporting standards for lower extremity arterial endovascular procedures. Society for Vascular Surgery/International Society for Cardiovascular Surgery. J. Vasc. Surg. 1993;17:1103–1107
- Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 1997;26:517–538
- Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med. Decis. Making. 1994;14:71–81
- Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy. Circulation. 1989;80:1544–1548
- Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease. J. Vasc. Surg. 1998;28:1072–1081
- The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. Am. Heart J. 2004;147:301–308
- Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996. Am. J. Public Health. 1999;89:1222–1227
- Cardiologists performing peripheral angioplasties: impact on utilization. Eff. Clin. Pract. 2001;4:191–198
- . Increases in peripheral interventional procedures by cardiologists—are patients or providers being served?. Eff. Clin. Pract. 2001;4:221–222
- The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions. J. Interv. Cardiol. 2002;15:381–386
- Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience. J. Interv. Cardiol. 2002;15:387–392
- Mortality over a period of 10 years in patients with peripheral arterial disease. N. Engl. J. Med. 1992;326:381–386
- The relationship between ankle-arm index and mortality in older men and women. J. Am. Geriatr. Soc. 1993;41:523–530
- Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 1996;25:1172–1181
- Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler. Thromb. Vasc. Biol. 1999;19:538–545
- Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329–1339
- Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000;342:145–153
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7–22
- Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation. 2002;106:1909–1912
- . An introduction to the bootstrap. New York (NY): Chapman & Hall; 1993;
- . Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 1996;15:361–387
- . Signal detection theory and ROC analysis. New York (NY): Academic Press; 1975;
- . Applied logistic regression. New York (NY): John Wiley & Sons; 1989;
- . Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J. Vasc. Surg. 2000;31:S1–S296
- Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting. Am. J. Cardiol. 2001;88:1064–1066
PII: S0002-8703(04)00509-5
doi: 10.1016/j.ahj.2004.08.015
© 2005 Mosby, Inc. All rights reserved.
« Previous
Next »
American Heart Journal
Volume 149, Issue 6
, Pages 1003-1008
, June 2005
